STC2 and ovarian cancer: Transwell assay revealed overexpression of STC2 enhances the invasion of ovarian cancer cells through matrigel or HUVEC -coated wells [118]; in accordance, overexpression of STC2 upregulates MMP-2 expression and enhances the invasive ability of neuroblastoma cells [47].